This paper contributes to critical voices on the issue of organisational responses to employee drug use. It does so by exploring symbolic readings of organisations' relations with drugs and drug-taking. Our focus is recent coverage of, and organisational responses to, the UK tabloid media's exposé of fashion supermodel Kate Moss's alleged cocaine use. We consider that the celebrity endorsement in this particular case highlights the ambiguities created by the symbolic associations between the organisation and the 'image' projected by the celebrity. Overall, we use this case to explore symbolic relationships between drugs, sex, femininity and organisation. Through highlighting these connections, we question further the rationality of organisational responses to employee drug use and, utilising Derrida's (1981) extension of Plato's notion of the pharmakon, consider whether workforce drug testing might be fruitfully seen as a symbolic mechanism for scapegoating and sacrifice in order to protect the organisation's (masculine) moral order.
IntroductionThis paper engages with the issue of managerial responses to workforce drug use. We are concerned in particular to extend existing readings of the symbolic roots of managerial interventions and prohibitions in this area. Our work draws out the connections, conflations and contradictions between organisational constructions of the meanings of drugs and the symbolism of female sexuality. The case of Kate Moss's dismissal by Swedish retailer H&M following the UK tabloid media's exposé of the fashion supermodel's alleged cocaine use is analysed here as a magnified illustration of some of the organisational attitudes toward drug use. We consider that the celebrity endorsement in this particular case highlights the ambiguities created by the symbolic associations between the organisation and the 'image' projected by the celebrity.We are using the concept of 'symbolism' in two related ways here. The first refers to the reading of social (organisational) practices as indicative of organisational values and/or a desired projection of corporate identity. As we note above and discuss further below in relation to workforce drugs-testing regimes, we suggest it may be instructive not to take such practices at face value, but instead to question what their social signifying function might be or, as Barthes (2000, 111) puts it, to ' … define and